


Healthcare Industry NewsFeed
HSMN NewsFeed - 1 Feb 2013
First U.S. Case Performed with Endosense’s TactiCath(R) Quartz Contact-Force Sensing Ablation Catheter
First U.S. Case Performed with Endosense’s TactiCath(R) Quartz Contact-Force Sensing Ablation Catheter
HSMN NewsFeed - 31 Jan 2013
Digirad Corporation Receives U.S. FDA 510(k) Market Clearance for Expanded Uses of ergo(TM) Imaging System
Digirad Corporation Receives U.S. FDA 510(k) Market Clearance for Expanded Uses of ergo(TM) Imaging System
HSMN NewsFeed - 30 Jan 2013
Mirna Therapeutics Inc. Appoints Clay B. Siegall, Ph.D., to Its Board of Directors
Mirna Therapeutics Inc. Appoints Clay B. Siegall, Ph.D., to Its Board of Directors
HSMN NewsFeed - 30 Jan 2013
Mercantile Court in Spain Rules in ZELTIQ(R) Aesthetics Patent Infringement Lawsuit Against Clinipro
Mercantile Court in Spain Rules in ZELTIQ(R) Aesthetics Patent Infringement Lawsuit Against Clinipro
HSMN NewsFeed - 30 Jan 2013
MyoKardia Appoints Industry Veteran Jonathan Fox, M.D., Ph.D., as Chief Medical Officer
MyoKardia Appoints Industry Veteran Jonathan Fox, M.D., Ph.D., as Chief Medical Officer
HSMN NewsFeed - 30 Jan 2013
Svelte Medical Systems Announces Treatment of First Patient in the DIRECT II Drug-Eluting Stent Study
Svelte Medical Systems Announces Treatment of First Patient in the DIRECT II Drug-Eluting Stent Study
HSMN NewsFeed - 29 Jan 2013
New Clinical Study Confirms Accuracy of Exergen Temporal Artery Thermometers Over Rectal
New Clinical Study Confirms Accuracy of Exergen Temporal Artery Thermometers Over Rectal
HSMN NewsFeed - 29 Jan 2013
Bionor Pharma Appoints Anker Lundemose as President and Chief Executive Officer
Bionor Pharma Appoints Anker Lundemose as President and Chief Executive Officer
HSMN NewsFeed - 29 Jan 2013
Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
HSMN NewsFeed - 29 Jan 2013
Spectranetics Announces Expansion Into Japan Peripheral Intervention Market
Spectranetics Announces Expansion Into Japan Peripheral Intervention Market
HSMN NewsFeed - 28 Jan 2013
New NCCN Guidelines for Patients(R) Available for Adolescents and Young Adults with Cancer
New NCCN Guidelines for Patients(R) Available for Adolescents and Young Adults with Cancer
HSMN NewsFeed - 28 Jan 2013
BrainStorm Cell Therapeutics Appoints Alon Natanson as Chief Executive Officer
BrainStorm Cell Therapeutics Appoints Alon Natanson as Chief Executive Officer
HSMN NewsFeed - 28 Jan 2013
Results from Active Biotech's Phase II/III ANYARA trial for the treatment of renal cell cancer
Results from Active Biotech's Phase II/III ANYARA trial for the treatment of renal cell cancer
HSMN NewsFeed - 28 Jan 2013
Genzyme’s LEMTRADA(TM) (alemtuzumab) Application for MS Accepted for Review by the FDA
Genzyme’s LEMTRADA(TM) (alemtuzumab) Application for MS Accepted for Review by the FDA
HSMN NewsFeed - 25 Jan 2013
FDA Approves OXYTROL(R) FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women
FDA Approves OXYTROL(R) FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women
HSMN NewsFeed - 25 Jan 2013
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Computed Radiography
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Computed Radiography
HSMN NewsFeed - 25 Jan 2013
Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
HSMN NewsFeed - 24 Jan 2013
Baxter Announces Agreement to Acquire Investigational Hemophilia Compound OBI-1 and Related Assets
Baxter Announces Agreement to Acquire Investigational Hemophilia Compound OBI-1 and Related Assets
HSMN NewsFeed - 24 Jan 2013
myoscience Device Receives FDA Clearance for Pain Management in Peripheral Nerve Tissue
myoscience Device Receives FDA Clearance for Pain Management in Peripheral Nerve Tissue
HSMN NewsFeed - 23 Jan 2013
IYIA Technologies Announces New Treatment Option for Foot Ulcers and Other Wounds That Won’t Heal
IYIA Technologies Announces New Treatment Option for Foot Ulcers and Other Wounds That Won’t Heal
HSMN NewsFeed - 23 Jan 2013
AngioDynamics to Acquire Microsulis' Leading Microwave Ablation Technology
AngioDynamics to Acquire Microsulis' Leading Microwave Ablation Technology
HSMN NewsFeed - 23 Jan 2013
Improved GORE(R) DrySeal Sheath with Hydrophilic Coating Launches in Europe
Improved GORE(R) DrySeal Sheath with Hydrophilic Coating Launches in Europe
HSMN NewsFeed - 22 Jan 2013
NCCN Guidelines(R) Recommend NovoTTF(TM) Therapy as a Standard Treatment Option for CNS Cancers
NCCN Guidelines(R) Recommend NovoTTF(TM) Therapy as a Standard Treatment Option for CNS Cancers
HSMN NewsFeed - 22 Jan 2013
Clinical Trials Advancing Proton Therapy Research Open at the CDH Proton Center, A ProCure Center
Clinical Trials Advancing Proton Therapy Research Open at the CDH Proton Center, A ProCure Center
HSMN NewsFeed - 22 Jan 2013
ARROW(R) UltraQuik(TM) Peripheral Nerve Block Needles Receive FDA 510(k) Clearance
ARROW(R) UltraQuik(TM) Peripheral Nerve Block Needles Receive FDA 510(k) Clearance
HSMN NewsFeed - 22 Jan 2013
Tau Therapeutics Hires Chief Medical Officer and VP of Operations and Strategy
Tau Therapeutics Hires Chief Medical Officer and VP of Operations and Strategy
HSMN NewsFeed - 21 Jan 2013
OrbusNeich's COMBO Dual Therapy Stent(TM) to Be Featured During AsiaPCR/SingLIVE 2013 Symposium
OrbusNeich's COMBO Dual Therapy Stent(TM) to Be Featured During AsiaPCR/SingLIVE 2013 Symposium
HSMN NewsFeed - 21 Jan 2013
Gore Receives CE Mark for Lower Profile Component for GORE(R) EXCLUDER(R) AAA Endoprosthesis
Gore Receives CE Mark for Lower Profile Component for GORE(R) EXCLUDER(R) AAA Endoprosthesis
